FDA Inspection 1218271 — Virginia Center for Reproductive Medicine

Virginia Center for Reproductive Medicine — FEI 3003939253

The FDA completed an inspection of Virginia Center for Reproductive Medicine on September 20, 2023 in Reston, VA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 20, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Reston, VA (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures